DK1812058T3 - Chlamydia Trachomatis antigener til vaccine og diagnostisk anvendelse - Google Patents

Chlamydia Trachomatis antigener til vaccine og diagnostisk anvendelse

Info

Publication number
DK1812058T3
DK1812058T3 DK05790937.6T DK05790937T DK1812058T3 DK 1812058 T3 DK1812058 T3 DK 1812058T3 DK 05790937 T DK05790937 T DK 05790937T DK 1812058 T3 DK1812058 T3 DK 1812058T3
Authority
DK
Denmark
Prior art keywords
vaccine
chlamydia trachomatis
diagnostic use
trachomatis antigens
antigens
Prior art date
Application number
DK05790937.6T
Other languages
English (en)
Inventor
Michael Theisen
Anja Olsen
Robert Leah
Frank Follmann
Klaus Jensen
Peter Andersen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of DK1812058T3 publication Critical patent/DK1812058T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK05790937.6T 2004-10-25 2005-10-11 Chlamydia Trachomatis antigener til vaccine og diagnostisk anvendelse DK1812058T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401633 2004-10-25
DKPA200501069 2005-07-19
PCT/DK2005/000651 WO2006045308A2 (en) 2004-10-25 2005-10-11 Chlamydia trachomatis antigens for vaccine and diagnostic use

Publications (1)

Publication Number Publication Date
DK1812058T3 true DK1812058T3 (da) 2012-09-17

Family

ID=35686446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05790937.6T DK1812058T3 (da) 2004-10-25 2005-10-11 Chlamydia Trachomatis antigener til vaccine og diagnostisk anvendelse

Country Status (11)

Country Link
US (1) US8889142B2 (da)
EP (3) EP2314314A3 (da)
JP (3) JP5024830B2 (da)
CA (2) CA2585011C (da)
CY (1) CY1113601T1 (da)
DK (1) DK1812058T3 (da)
ES (1) ES2389562T3 (da)
PL (1) PL1812058T3 (da)
PT (1) PT1812058E (da)
SI (1) SI1812058T1 (da)
WO (1) WO2006045308A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
JP2008544745A (ja) * 2005-05-12 2008-12-11 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓのための免疫原性組成物
US9259463B2 (en) * 2006-01-16 2016-02-16 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chlamydia vaccine
EP1970708A1 (de) * 2007-03-07 2008-09-17 Mikrogen Molekularbiologische Entwicklungs-GmbH Biochip und Verfahren zum selektiven Nachweis von Chlamydia trachomatis-Infektionen
JP2010526070A (ja) * 2007-05-01 2010-07-29 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム Ｃｈｌａｍｙｄｉａ感染及び疾患の診断ならびに治療のための薬剤としてのＣｈｌａｍｙｄｉａ抗原
WO2010027442A1 (en) * 2008-08-26 2010-03-11 Becton, Dickinson And Company Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis cytotoxin gene
US9068007B2 (en) 2008-10-09 2015-06-30 Board Of Regents, The University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
AU2010207828B2 (en) * 2009-01-29 2016-07-14 British Columbia Cancer Agency Branch Compositions comprising Chlamydia antigens
US20120028279A1 (en) * 2009-03-24 2012-02-02 Bruce Acres Biomarker for monitoring patients
WO2011063133A1 (en) * 2009-11-18 2011-05-26 Auburn University LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE
EP2544715A2 (en) * 2010-03-09 2013-01-16 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
ES2788728T3 (es) 2010-05-28 2020-10-22 Spixia Biotechnology Ab Antígeno de la MOMP quimérica, método y uso
JP2013545448A (ja) * 2010-10-20 2013-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド クラミジア抗原及びその使用
JP2015501293A (ja) * 2011-09-30 2015-01-15 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア クラミジア抗原組成物およびその使用
EP2854777B1 (en) * 2012-05-29 2016-12-28 The Research Foundation for the State University of New York Combined therapy and prophylaxis for genital tract infections
ITNA20120046A1 (it) * 2012-08-02 2014-02-03 No Self S R L Uso di acidi nucleici di sistemi biologici parassiti, patogeni e infestanti per l'inibizione e/o controllo degli stessi sistemi
CA2907199C (en) * 2013-03-18 2023-10-17 Statens Serum Institut Vaccines against chlamydia sp.
WO2015106345A1 (en) 2014-01-16 2015-07-23 Mcmaster University Type iii secretion injectisome proteins for treatment and prevention of chlamydial infections
NL2022581B1 (en) * 2019-02-14 2020-08-27 Koppert Bv Composition comprising a mixture of dna molecules, uses thereof as biological inhibitor and method for production
WO2022140038A1 (en) * 2020-12-23 2022-06-30 Daykin Molecular Systems, LLC Nucleic acid stabilizing solution for vaccines, therapy, diagnostics, storage, and transport
CN117106078B (zh) * 2023-07-18 2024-09-17 华南农业大学 一种水稻橙叶植原体抗原膜蛋白多克隆抗体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
GB9626864D0 (en) * 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
PT832093E (pt) 1995-06-07 2006-12-29 Sanofi Pasteur Inc Expressão de lipoproteínas
US6136958A (en) 1996-09-30 2000-10-24 Genentech, Inc. Antibodies to vertebrate smoothened proteins
EP0892061A3 (en) * 1997-07-18 1999-02-24 Smithkline Beecham Corporation The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
BR9814878A (pt) 1997-11-21 2000-10-03 Genset Sa Sequência genÈmica e polipeptìdeos de chlamydia pneumoniae, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
WO1999028475A2 (en) * 1997-11-28 1999-06-10 Genset Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6736222B2 (en) 2001-11-05 2004-05-18 Vector Magnetics, Llc Relative drill bit direction measurement
NZ546711A (en) * 2001-12-12 2008-06-30 Chiron Srl Immunisation against chlamydia trachomatis
DE602004028705D1 (de) * 2003-02-24 2010-09-30 Pasteur Institut ANWENDUNG DES CPn104 POLYPEPTIDS AUS CHLAMYDIA PNEUMONIAE ODER DESSEN ANTIKÖRPER ZUR DIAGNOSE EINER CHLAMYDIA INFEKTION
MXPA05013260A (es) * 2003-06-26 2006-03-09 Chiron Corp Composiciones inmunogenicas para chlamydia trachomatis.
US20090028891A1 (en) * 2004-11-11 2009-01-29 Queensland University Of Technology Chlamydia Antigens and Uses Thereof

Also Published As

Publication number Publication date
SI1812058T1 (sl) 2013-02-28
ES2389562T3 (es) 2012-10-29
JP2012102108A (ja) 2012-05-31
CA2585011C (en) 2014-02-18
EP1812058A2 (en) 2007-08-01
WO2006045308A3 (en) 2006-12-07
JP5024830B2 (ja) 2012-09-12
CA2585011A1 (en) 2006-05-04
EP2269636A3 (en) 2011-04-06
EP1812058B1 (en) 2012-06-13
PT1812058E (pt) 2012-09-17
EP2314314A2 (en) 2011-04-27
JP2008520550A (ja) 2008-06-19
WO2006045308A2 (en) 2006-05-04
US8889142B2 (en) 2014-11-18
PL1812058T3 (pl) 2012-11-30
WO2006045308A8 (en) 2011-08-11
EP2269636A2 (en) 2011-01-05
EP2314314A3 (en) 2011-05-11
CY1113601T1 (el) 2016-06-22
US20090304722A1 (en) 2009-12-10
JP2013231050A (ja) 2013-11-14
CA2820140A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
DK1812058T3 (da) Chlamydia Trachomatis antigener til vaccine og diagnostisk anvendelse
DK1740207T3 (da) Antigenafgivelsesvektorer og konstrukter
BRPI0814594A2 (pt) Composições e métodos adjuvantes de antígeno
FI20060449A0 (fi) Mammografiamenetelmä ja mammografialaite
DE602006009191D1 (de) Bildaufnahmegerät und -verfahren
DE602005013852D1 (de) Kopfstützenvorrichtung
DK1955102T3 (da) Fremgangsmåde og indretning til konfokal billedbehandling
ITMI20041020A1 (it) Dispositivo di chiusura per mobili
DE602005022691D1 (de) Bilderzeugungsvorrichtung
DE602005010892D1 (de) Ventilhaltevorrichtung
DK1817055T3 (da) Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DE602005002786D1 (de) Bilderzeugungsvorrichtung
ITMI20042079A1 (it) Dispositivo di diagnosi
DK1976884T3 (da) Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.
DE602005015751D1 (de) Bilderzeugungsvorrichtung
DK1840121T3 (da) Glycinderivat og anvendelse heraf
ZA200608278B (en) Stabilised TAT Antigen and the use thereof for anit-HIV Vaccination
BRPI0615481A2 (pt) peptídeos antigênicos e sua utilização
DE602005016738D1 (de) Bilderzeugungsvorrichtung
DE602005014205D1 (de) Bilderzeugungseinrichtung
ITMO20040105A1 (it) Apparato di lancio
ATE373942T1 (de) Heizeinrichtung
ITUD20040099A1 (it) Dispositivo e procedimento per la formazione
NO20072240L (no) Antigener fra piscirickettsia salomius og bruken av disse